Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: April 24, 2017


Six Johns Hopkins physicians were elected to the Association of American Physicians at the annual meeting of the organization April 21-23 in Chicago.
 

Released: April 24, 2017

Closing disclosure gap for lesbian, gay and bisexual community should improve care


A study that surveyed a national sample of emergency department health care providers and adult patients suggests that patients are substantially more willing to disclose their sexual orientation than health care workers believe.

Released: April 20, 2017

Study in mice identifies neurons that sense touch and motion, a combo needed to actively perceive the external world


Working with genetically engineered mice — and especially their whiskers — Johns Hopkins researchers report they have identified a group of nerve cells in the skin responsible for what they call “active touch,” a combination of  motion and sensory feeling needed to navigate the external world. The discovery of this basic sensory mechanism, described online April 20 in the journal Neuron, advances the search for better “smart” prosthetics for people, ones that provide more natural sensory feedback to the brain during use.

Released: April 20, 2017


The Johns Hopkins Center for Inherited Disease Research (CIDR) marked its 20-year history supporting large-scale scientific collaboration by securing funding to the center through 2023.  CIDR successfully competed for a seven-year contract from the National Institutes of Health (NIH) providing up to $213 million in research funding. The renewal contract enables NIH-funded researchers to use CIDR’s sequencing, high-throughput genotyping, analysis and informatics services for a wide array of studies exploring genetic contributions to human health and disease.

Released: April 19, 2017

Mutant forms of HIV complicate disease monitoring and distract the immune system from the functional virus


Researchers at Johns Hopkins and George Washington universities report new evidence that proteins created by defective forms of HIV long previously believed to be harmless actually interact with our immune systems and are actively monitored by a specific type of immune cell, called cytotoxic T cells.

Released: April 19, 2017

Use of sestamibi SPECT/CT scan could spare patients with benign kidney tumors from unneeded surgery


The latest in a series of studies led by researchers at Johns Hopkins Medicine shows that addition of a widely available, noninvasive imaging test called 99mTc-sestamibi SPECT/CT to CT or MRI increases the accuracy of kidney tumor classification. The research team reports that the potential improvement in diagnostic accuracy will spare thousands of patients each year in the United States alone from having to undergo unnecessary surgery.

Released: April 18, 2017

New evidence that, contrary to dogma, a healthy adult gut loses and regenerates a third of its nerve cells weekly


Johns Hopkins researchers today published new evidence refuting the long-held scientific belief that the gut nerve cells we’re born with are the same ones we die with.

Released: April 18, 2017


Although human population studies have linked air pollution to chronic inflammation of nasal and sinus tissues, direct biological and molecular evidence for cause and effect has been scant. Now, Johns Hopkins researchers report that experiments in mice continually exposed to dirty air have revealed that direct biological effect.

Released: April 17, 2017


After nearly 40 years of searching, Johns Hopkins researchers report they have identified a part of the human genome that appears to block an RNA responsible for keeping only a single X chromosome active when new female embryos are formed, effectively allowing for the generally lethal activation of more than one X chromosome during development. Because so-called X-inactivation is essential for normal female embryo development in humans and other mammals, and two activated X chromosomes create an inherently fatal condition, the research may help explain the worldwide human sex ratio that has slightly favored males over females for as long as science has been able to measure it. The results appear online in the April 12 issue of the journal PLOS ONE.

Released: April 13, 2017

Johns Hopkins nurses earn more top honors than nurses from any other health system in the region


Baltimore magazine is honoring 11 Johns Hopkins nurses and nurse leaders for their extraordinary contributions to health care in its third annual “Excellence in Nursing” issue this May.

Released: April 12, 2017


The American Academy of Arts and Sciences today announced the election of 228 new members, including Paul B. Rothman, M.D. and Arturo Casadevall, M.D., of The Johns Hopkins University. 

Released: April 11, 2017


At the annual “Research Matters” conference on Wednesday, April 12, scientists at Maryland’s two academic cancer centers will meet to discuss how scientists are using advanced imaging methods to develop better ways pinpoint and track cancer cells — down to the microscopic level — and precisely target each cell with anti-cancer drugs.

Released: April 7, 2017


Johns Hopkins Kimmel Cancer Center researchers received the following honors and awards at the 2017 annual meeting of the American Association for Cancer Research, April 1-5 in Washington, D.C.

Released: April 5, 2017


In a clinical trial conducted among adults in 11 hospitals, researchers have shown that a hand-held EEG device approved in 2016 by the U.S. Food and Drug Administration that is commercially available can quickly and with 97 percent accuracy rule out whether a person with a head injury likely has brain bleeding and needs further evaluation and treatment.

Released: April 5, 2017


In a small pilot study of men with schizophrenia, researchers at Johns Hopkins Medicine and Sheppard Pratt Health System say they have evidence that adding probiotics — microorganisms, such as bacteria found in yogurts — to the patients’ diets may help treat yeast infections and ease bowel problems. Probiotics may also decrease delusions and hallucinations, but in the study, these psychiatric benefits mostly affected those without a history of yeast infections.

Released: April 4, 2017


See below for brief descriptions of research scheduled for presentation by Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy scientists at the 2017 Annual Meeting of the American Association for Cancer Research, April 1 – 5 in Washington, D.C.

Released: April 4, 2017


As part of the Maryland Trauma System distracted driving awareness statewide initiative, Johns Hopkins Health System Trauma Centers will host events to educate people about the dangers of distracted driving. The events are free and open to the public.

Released: April 3, 2017

Seventy percent of patients who kept their gallbladders despite biliary pancreatitis had no recurrence four years later


Johns Hopkins researchers say that the findings they published in the current edition of The American Journal of Gastroenterology could have important implications for the field of personalized medicine.

Released: April 3, 2017

Reverse triage, a strategy shown to be potentially effective in sudden increases of adult inpatients, may also be a useful tactic for pediatric hospitals.


A school mass shooting. A bus accident involving children. Heat-related illnesses at a large outdoor event. These are all horrific incidents that could send dozens of young patients to a hospital at one time. When many hospitals nationwide are already filled to capacity, how can hospitals handle an unexpected surge of pediatric patients?

Released: April 3, 2017


More than seven years after the start of one of the first clinical trials of the immunotherapy drug nivolumab, researchers at the Johns Hopkins Kimmel Cancer Center report that the five-year survival estimate for a limited subset of people with advanced nonsmall cell lung cancer taking the drug is 16 percent, compared with a historical survival rate for that group of 1 to 4 percent.